Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nichi-Iko

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nichi-Iko's Japan sales performance.

AZ strengthens Daiichi Sankyo partnership with new ADC deal

AZ strengthens Daiichi Sankyo partnership with new ADC deal Both companies will jointly develop and commercialise DS-1062 worldwide, apart from in Japan where Daiichi will retain exclusive rights.

Tecentriq misses the mark in advanced ovarian cancer

Tecentriq misses the mark in advanced ovarian cancer AZ is awaiting additional decisions on Imfinzi in first-line ES-SCLC in Europe and Japan before the end of the year, and the drug is already approved for this indication

Novartis reveals full phase 3 results for Enerzair Breezhaler

Novartis reveals full phase 3 results for Enerzair Breezhaler So far, medium- and high-doses of Novartis’ drug have been approved in Japan, and high-dose Enerzair Breezhaler has also been approved in the EU and Canada, with these regulatory

Multichannel engagement and the need for greater understanding of European markets

Multichannel engagement and the need for greater understanding of European markets and Japan in the uptake of digital marketing – the volume share of digital promotional activity is just 11% compared with 21% in the US and 47% in Japan.

EMA fast-tracks review of AZ/Daiichi Sankyo’s HER2 drug

EMA fast-tracks review of AZ/Daiichi Sankyo’s HER2 drug The companies have split the cost of bringing the drug to market and will share in global profits, with the exception of Japan where Daiichi retains exclusive rights.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics